Late Breaking Abstract - Increased Substance P levels in COVID-19 hospitalized patients

S. Smieszek (Washington, United States of America)

Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Session: Late breaking basic and translational science of SARS-Cov2 and COVID-19
Session type: Oral Presentation
Number: 4114

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Smieszek (Washington, United States of America). Late Breaking Abstract - Increased Substance P levels in COVID-19 hospitalized patients. 4114

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019


Late Breaking Abstract - Characteristics of T2-biomarker low severe asthma patients in the UK Severe Asthma Registry (UKSAR)
Source: International Congress 2019 – Asthma epidemiology in the 21st century
Year: 2019

Late Breaking Abstract - Frequency and characteristics of TB relapses
Source: International Congress 2017 – Late-breaking studies in pulmonary diseases
Year: 2017



Late Breaking Abstract - Pulmonary function in children and adolescents after COVID-19
Source: Virtual Congress 2021 – Best of paediatric physiology and sleep research
Year: 2021



Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019




Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients
Source: International Congress 2017 – Novel mechanisms and treatments for COPD
Year: 2017



Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021


Late Breaking Abstract - Outpatient pulmonary rehabilitation in patients with long COVID
Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care
Year: 2021


Late Breaking Abstract: Expression of S100A4 in COPD
Source: Annual Congress 2010 - Novel mechanisms in COPD
Year: 2010

Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021


Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018




Late Breaking Abstract - Characterization of hospitalized patients with Influenza: a retrospective study
Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers
Year: 2017

Late Breaking Abstract - Hospitalized patients aged =70 years were disproportionately affected by COVID-19
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Year: 2021


Late Breaking Abstract - Long COVID-19 symptoms including fatigue are more frequent in females independently of COVID-19 treatment
Source: Virtual Congress 2021 – Biological and functional markers of COVID-19
Year: 2021


Late Breaking Abstract - Comparison of clinical characteristics between severe adult asthmatics in Brazil(ProAR) and Europe(U-BIOPRED).
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Late Breaking Abstract - Characteristics and treatment of patients with comorbid COPD and heart failure
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018


Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Late Breaking Abstract - The DIAMORFOSIS (DIAgnosis and Management Of lung canceR and FibrOSIS) survey.
Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings
Year: 2019